Cullinan Oncology Ownership 2024 | Who Owns Cullinan Oncology Now?


OverviewForecastFinancialsChart

Institutional Ownership

92.01%

Insider Ownership

4.54%

Retail Ownership

3.45%

Institutional Holders

115.00

Cullinan Oncology Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIOIMPACT CAPITAL LLC17.87%20.95%7,648,268--130,326,487Mar 31, 2024
BVF INC/IL7.47%1.50%3,196,701--54,471,785Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP6.83%9.96%2,924,842-495,000-14.47%49,839,308Mar 31, 2024
FRANKLIN RESOURCES INC6.30%0.01%2,696,762-584,518-17.81%45,952,827Mar 31, 2024
BLACKROCK INC.5.68%0.00%2,428,993-33,281-1.35%41,390,042Mar 31, 2024
VANGUARD GROUP INC4.15%0.00%1,774,3452,9020.16%30,234,838Mar 31, 2024
STATE STREET CORP3.33%0.00%1,425,459860,055152.11%24,289,821Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.15%0.81%1,348,0151,348,015100.00%22,970,176Mar 31, 2024
BRAIDWELL LP2.90%0.68%1,240,865--21,144,340Mar 31, 2024
NEXTECH INVEST LTD.2.85%3.30%1,221,145--20,808,311Mar 31, 2024
MORGAN STANLEY2.69%0.00%1,152,644232,74525.30%19,641,057Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.66%0.34%1,138,5311,138,531100.00%19,400,568Mar 31, 2024
CITADEL ADVISORS LLC2.59%0.00%1,109,171-23,718-2.09%18,900,274Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP2.32%0.00%993,37777,6198.48%16,927,144Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.2.22%0.03%950,000950,000100.00%16,188,000Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.64%0.97%700,000700,000100.00%11,928,000Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.58%0.00%677,33021,6663.30%11,543,654Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP1.47%0.32%626,929--10,682,870Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC1.33%1.01%571,138-200,000-25.94%9,732,192Mar 31, 2024
DEUTSCHE BANK AG\1.28%0.00%549,2763,6920.68%9,359,663Mar 31, 2024

Cullinan Oncology's largest institutional shareholder is BIOIMPACT CAPITAL LLC, holding 17.87% of the company's total share outstanding, currently valued at $130.33M. The top 10 institutional shareholders own together 60.54% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIOIMPACT CAPITAL LLC17.87%20.95%7,648,268--130,326,487Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP6.83%9.96%2,924,842-495,000-14.47%49,839,308Mar 31, 2024
NEXTECH INVEST LTD.2.85%3.30%1,221,145--20,808,311Mar 31, 2024
BVF INC/IL7.47%1.50%3,196,701--54,471,785Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC1.33%1.01%571,138-200,000-25.94%9,732,192Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.64%0.97%700,000700,000100.00%11,928,000Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.15%0.81%1,348,0151,348,015100.00%22,970,176Mar 31, 2024
BRAIDWELL LP2.90%0.68%1,240,865--21,144,340Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.60%0.55%258,588-41,412-13.80%4,406,340Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.42%0.37%178,396-351,481-66.33%3,039,868Mar 31, 2024
BIRCHVIEW CAPITAL, LP0.06%0.35%25,114--427,943Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.66%0.34%1,138,5311,138,531100.00%19,400,568Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP1.47%0.32%626,929--10,682,870Mar 31, 2024
PFM HEALTH SCIENCES, LP0.60%0.20%255,967255,967100.00%4,361,678Mar 31, 2024
ORBIMED ADVISORS LLC1.21%0.16%517,606-27,242-5.00%8,820,006Mar 31, 2024
VIRTUS ETF ADVISERS LLC0.02%0.09%10,181-698-6.42%173,484Mar 31, 2024
NEBULA RESEARCH & DEVELOPMENT LLC0.06%0.09%24,65324,653100.00%420,087Mar 31, 2024
UBS OCONNOR LLC0.14%0.07%59,3525,0009.20%1,011,358Mar 31, 2024
ALGERT GLOBAL LLC0.19%0.05%79,68038,66094.25%1,358,000Mar 31, 2024
CORNERCAP INVESTMENT COUNSEL INC0.04%0.05%18,579-139-0.74%316,586Mar 31, 2024

The largest Cullinan Oncology shareholder by % of total assets is BIOIMPACT CAPITAL LLC. The company owns 7.65M shares of Cullinan Oncology (CGEM), representing 20.95% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARADIGM BIOCAPITAL ADVISORS LP3.15%0.81%1,348,0151,348,015100.00%22,970,176Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.66%0.34%1,138,5311,138,531100.00%19,400,568Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.2.22%0.03%950,000950,000100.00%16,188,000Mar 31, 2024
STATE STREET CORP3.33%0.00%1,425,459860,055152.11%24,289,821Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.64%0.97%700,000700,000100.00%11,928,000Mar 31, 2024
AMERIPRISE FINANCIAL INC0.98%0.00%420,217365,296665.13%7,160,497Mar 31, 2024
PFM HEALTH SCIENCES, LP0.60%0.20%255,967255,967100.00%4,361,678Mar 31, 2024
MORGAN STANLEY2.69%0.00%1,152,644232,74525.30%19,641,057Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.27%0.00%115,112108,2661581.45%1,961,508Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.23%0.01%97,05597,055100.00%1,653,817Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP2.32%0.00%993,37777,6198.48%16,927,144Mar 31, 2024
CITIGROUP INC0.20%0.00%85,57475,004709.59%1,458,181Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.16%0.00%68,35868,358100.00%1,164,821Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.75%0.01%321,10057,01221.59%5,472,000Mar 31, 2024
GOLDMAN SACHS GROUP INC0.40%0.00%169,36741,05231.99%2,886,014Mar 31, 2024
ALGERT GLOBAL LLC0.19%0.05%79,68038,66094.25%1,358,000Mar 31, 2024
INVESCO LTD.0.11%0.00%47,40736,784346.27%807,815Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.09%0.00%36,40136,401100.00%620,273Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.08%0.00%34,61534,615100.00%589,840Mar 31, 2024
STRS OHIO0.07%0.00%31,90031,900100.00%543,000Mar 31, 2024

As of Mar 31 2024, Cullinan Oncology's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.35M stocks of CGEM, valued at $22.97M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AMERICAN INTERNATIONAL GROUP, INC.0.03%0.00%12,742-1,223,822-98.97%217,124Mar 31, 2024
FRANKLIN RESOURCES INC6.30%0.01%2,696,762-584,518-17.81%45,952,827Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP6.83%9.96%2,924,842-495,000-14.47%49,839,308Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.42%0.37%178,396-351,481-66.33%3,039,868Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----233,366-100.00%-Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----225,000-100.00%-Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC1.33%1.01%571,138-200,000-25.94%9,732,192Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC----127,284-100.00%-Mar 31, 2024
VERITION FUND MANAGEMENT LLC----112,873-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.14%0.01%60,074-80,926-57.39%1,023,660Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC0.20%0.03%84,234-75,778-47.36%1,435,347Mar 31, 2024
TWO SIGMA INVESTMENTS, LP----50,342-100.00%-Mar 31, 2024
BARCLAYS PLC0.09%0.00%40,192-45,032-52.84%685,000Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.60%0.55%258,588-41,412-13.80%4,406,340Mar 31, 2024
TREXQUANT INVESTMENT LP----34,955-100.00%-Mar 31, 2024
BLACKROCK INC.5.68%0.00%2,428,993-33,281-1.35%41,390,042Mar 31, 2024
ORBIMED ADVISORS LLC1.21%0.16%517,606-27,242-5.00%8,820,006Mar 31, 2024
CITADEL ADVISORS LLC2.59%0.00%1,109,171-23,718-2.09%18,900,274Mar 31, 2024
HSBC HOLDINGS PLC----21,816-100.00%-Mar 31, 2024
SQUAREPOINT OPS LLC----20,067-100.00%-Mar 31, 2024

As of Mar 31 2024, Cullinan Oncology's biggest institutional seller is AMERICAN INTERNATIONAL GROUP, INC.. The company sold -1.22M shares of CGEM, valued at $217.12K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARADIGM BIOCAPITAL ADVISORS LP3.15%0.81%1,348,0151,348,015100.00%22,970,176Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.66%0.34%1,138,5311,138,531100.00%19,400,568Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.64%0.97%700,000700,000100.00%11,928,000Mar 31, 2024
PFM HEALTH SCIENCES, LP0.60%0.20%255,967255,967100.00%4,361,678Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.23%0.01%97,05597,055100.00%1,653,817Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.16%0.00%68,35868,358100.00%1,164,821Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.09%0.00%36,40136,401100.00%620,273Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.08%0.00%34,61534,615100.00%589,840Mar 31, 2024
STRS OHIO0.07%0.00%31,90031,900100.00%543,000Mar 31, 2024
NEBULA RESEARCH & DEVELOPMENT LLC0.06%0.09%24,65324,653100.00%420,087Mar 31, 2024
JUMP FINANCIAL, LLC0.05%0.01%21,69021,690100.00%369,598Mar 31, 2024
PROFUND ADVISORS LLC0.04%0.01%15,26315,263100.00%260,082Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.03%0.00%14,70414,704100.00%251,000Mar 31, 2024
0.00%0.00%1,2731,273100.00%21,688Mar 31, 2024
NEWEDGE ADVISORS, LLC0.00%0.00%723723100.00%12,320Mar 31, 2024
PACER ADVISORS, INC.0.00%-450450100.00%7,668Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--55100.00%85Mar 31, 2024

Cullinan Oncology's largest new institutional shareholder by number of shares is PARADIGM BIOCAPITAL ADVISORS LP, purchased 1.35M shares, valued at $22.97M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----233,366-100.00%-Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----225,000-100.00%-Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC----127,284-100.00%-Mar 31, 2024
VERITION FUND MANAGEMENT LLC----112,873-100.00%-Mar 31, 2024
TWO SIGMA INVESTMENTS, LP----50,342-100.00%-Mar 31, 2024
TREXQUANT INVESTMENT LP----34,955-100.00%-Mar 31, 2024
HSBC HOLDINGS PLC----21,816-100.00%-Mar 31, 2024
SQUAREPOINT OPS LLC----20,067-100.00%-Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----17,844-100.00%-Mar 31, 2024
ANNANDALE CAPITAL, LLC----12,000-100.00%-Mar 31, 2024
BAILARD, INC.----10,800-100.00%-Mar 31, 2024
PRINCIPAL FINANCIAL GROUP INC----10,692-100.00%-Mar 31, 2024
GSA CAPITAL PARTNERS LLP----10,246-100.00%-Mar 31, 2024
VOYA INVESTMENT MANAGEMENT LLC----10,061-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----10,000-100.00%-Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----2,852-100.00%-Mar 31, 2024
RUSSELL INVESTMENTS GROUP, LTD.----2,300-100.00%-Mar 31, 2024

Cullinan Oncology's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -0.23M shares, valued at -, as of undefined.

Cullinan Oncology Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Tema ETF Trust0.36%16,1472411.52%Feb 29, 2024
CORNERCAP GROUP OF FUNDS /VA/0.11%8,0538,053-Sep 30, 2022
FIDELITY ADVISOR SERIES VII0.05%465,700--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.03%14,892--Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.02%351,360--Dec 31, 2023
FIDELITY CAPITAL TRUST0.02%249,784--Jan 31, 2024
IndexIQ ETF Trust0.01%31,561-2,463-7.24%Jan 31, 2024
FIDELITY SECURITIES FUND0.01%1,070,200--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.01%92,8752,3052.54%Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%3,629--Dec 31, 2023
ETFis Series Trust I0.01%9,6431,23914.74%Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%41,579--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.01%146,569--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%2,107,991639,12243.51%Dec 31, 2023
Nushares ETF Trust0.00%28,0264,48419.05%Jan 31, 2024
Harbor ETF Trust0.00%14,4634,14040.10%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%660--Dec 31, 2023
ALPS ETF Trust0.00%28,826--Feb 29, 2024
TARGET PORTFOLIO TRUST0.00%42,3008,40024.78%Jan 31, 2024
FIDELITY CONTRAFUND0.00%129,532--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%337,67926,8158.63%Feb 29, 2024
Cambria ETF Trust0.00%12,76012,760-Jan 31, 2024
FIDELITY ADVISOR SERIES I0.00%193,200--Feb 29, 2024
ETF Series Solutions0.00%16,5612,65319.08%Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%16,773--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%170,8645,8723.56%Feb 29, 2024
VICTORY PORTFOLIOS0.00%27,770--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.00%53,500--Feb 29, 2024
Calvert Variable Products, Inc.0.00%1,984--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%3,044--Dec 31, 2023
Dimensional ETF Trust0.00%290,48319,1327.05%Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%18,523--Dec 31, 2023
GOLDMAN SACHS TRUST0.00%97,037--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%554,13876,89116.11%Jan 31, 2024
Principal Exchange-Traded Funds0.00%6,456-990-13.30%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%4,500--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%1,440,145--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%44,93710,08528.94%Feb 29, 2024
Direxion Shares ETF Trust0.00%60,157--Jan 31, 2024
Forethought Variable Insurance Trust0.00%1,500--Dec 29, 2023
VANGUARD WORLD FUND0.00%79,82119,96433.35%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%10,061-693-6.44%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,139--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%11,305--Feb 29, 2024
Trust for Advised Portfolios0.00%3,337--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%427--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,932-137-6.62%Dec 31, 2023
Goldman Sachs ETF Trust0.00%10,834--Feb 29, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%211-10,589-98.05%Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%11,7507,826199.44%Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%7,300--Dec 31, 2023
EQ ADVISORS TRUST0.00%87,250-116-0.13%Dec 31, 2023
SA FUNDS INVESTMENT TRUST0.00%1,139--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%113,50119,84921.19%Feb 29, 2024
RBC FUNDS TRUST0.00%4,900--Dec 29, 2023
RYDEX SERIES FUNDS0.00%217--Dec 31, 2023
ProFunds0.00%36815068.81%Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,020--Dec 31, 2023
RBB FUND, INC.0.00%3,244--Feb 29, 2024
VALIC Co I0.00%9,9237518.19%Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%2,714--Dec 31, 2023
RUSSELL INVESTMENT FUNDS0.00%1,900--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%8,649--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%3,849-6,350-62.26%Dec 31, 2023
PROSHARES TRUST0.00%6,9851,18720.47%Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%108--Dec 31, 2023
NORTHERN FUNDS0.00%23,3891,4266.49%Dec 29, 2023
Guggenheim Active Allocation Fund0.00%154--Feb 29, 2024
PENN SERIES FUNDS INC0.00%600--Dec 29, 2023
SEASONS SERIES TRUST0.00%493493-Dec 31, 2023
TRUST FOR PROFESSIONAL MANAGERS0.00%5,393--Feb 29, 2024
SPDR SERIES TRUST0.00%615,316--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%14--Dec 31, 2023
PGIM ETF TRUST0.00%748--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%23,669--Dec 31, 2023
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%2,237--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%871--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%2,9292218.16%Jan 31, 2024
Brinker Capital Destinations Trust0.00%436--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%7,345--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%832440.68%Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%10,633--Dec 31, 2023
Invesco Exchange-Traded Fund Trust II0.00%1,14939853.00%Feb 29, 2024
Brighthouse Funds Trust II0.00%7,747--Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%1,353--Feb 29, 2024
BLACKROCK LARGE CAP SERIES FUNDS, INC.0.00%147--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%9,439-3,363-26.27%Dec 31, 2023
PACIFIC SELECT FUND0.00%9,696-450-4.44%Dec 31, 2023
T. Rowe Price Multi-Strategy Total Return Fund, Inc.0.00%357--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,026--Dec 31, 2023
Bridge Builder Trust0.00%11,4531,90019.89%Dec 31, 2023
Brighthouse Funds Trust I0.00%12,900--Dec 31, 2023
WILSHIRE MUTUAL FUNDS INC0.00%310--Dec 31, 2023
SPDR INDEX SHARES FUNDS0.00%18221.11%Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%3,008--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%10,200--Feb 29, 2024
John Hancock Funds II0.00%2,839--Feb 29, 2024

Cullinan Oncology's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 16.15K shares, compromising 0.36% of its total assets.

Cullinan Oncology Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241152.68%
31 Dec, 231127.69%
30 Sep, 23104-0.95%
30 Jun, 231053.96%
31 Mar, 231014.12%
31 Dec, 22972.11%
30 Sep, 229511.76%
30 Jun, 22857.59%
31 Mar, 22796.76%
31 Dec, 217412.12%
30 Sep, 2166-7.04%
30 Jun, 21711.43%
31 Mar, 2170-

As of 31 Mar 24, 115 institutions are holding Cullinan Oncology's shares, representing an increase of 2.68% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2439,373,0466.94%
31 Dec, 2336,818,479-3.05%
30 Sep, 2337,976,8133.09%
30 Jun, 2336,837,57314.25%
31 Mar, 2332,243,537-14.47%
31 Dec, 2237,699,4681.89%
30 Sep, 2237,000,514-1.52%
30 Jun, 2237,571,5071.94%
31 Mar, 2236,856,3341.37%
31 Dec, 2136,359,3587.29%
30 Sep, 2133,889,4665.08%
30 Jun, 2132,250,7342.96%
31 Mar, 2131,323,171-

Cullinan Oncology (CGEM) has 39.37M shares outstanding as of 31 Mar 24, up 6.94% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2492.01%1.24%
31 Dec, 2386.16%0.95%
30 Sep, 2395.06%1.16%
30 Jun, 2390.55%1.44%
31 Mar, 2379.26%1.14%
31 Dec, 2283.47%1.27%
30 Sep, 2281.12%1.16%
30 Jun, 2283.73%1.22%
31 Mar, 2282.95%1.16%
31 Dec, 2184.41%1.39%
30 Sep, 2178.02%1.41%
30 Jun, 2174.49%1.34%
31 Mar, 2174.62%-

As of 31 Mar 24, Cullinan Oncology is held by 92.01% institutional shareholders, representing a 1.24% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2461-10.29%
31 Dec, 236847.83%
30 Sep, 2346-9.80%
30 Jun, 23518.51%
31 Mar, 2347-12.96%
31 Dec, 2254-3.57%
30 Sep, 225624.44%
30 Jun, 224540.63%
31 Mar, 2232-30.43%
31 Dec, 214615.00%
30 Sep, 2140-
30 Jun, 2140-42.86%
31 Mar, 2170-

61 institutional shareholders have increased their position in CGEM stock as of 31 Mar 24 compared to 68 in the previous quarter (a -10.29% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 243656.52%
31 Dec, 2323-23.33%
30 Sep, 2330-21.05%
30 Jun, 233815.15%
31 Mar, 233350.00%
31 Dec, 2222-15.38%
30 Sep, 222613.04%
30 Jun, 2223-20.69%
31 Mar, 222981.25%
31 Dec, 211645.45%
30 Sep, 2111-42.11%
30 Jun, 2119-
31 Mar, 21--

36 institutional shareholders have reduced their position in CGEM stock as of 31 Mar 24 compared to 23 in the previous quarter (a 56.52% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241152.68%39,373,0466.94%92.01%1.24%61-10.29%3656.52%
31 Dec, 231127.69%36,818,479-3.05%86.16%0.95%6847.83%23-23.33%
30 Sep, 23104-0.95%37,976,8133.09%95.06%1.16%46-9.80%30-21.05%
30 Jun, 231053.96%36,837,57314.25%90.55%1.44%518.51%3815.15%
31 Mar, 231014.12%32,243,537-14.47%79.26%1.14%47-12.96%3350.00%
31 Dec, 22972.11%37,699,4681.89%83.47%1.27%54-3.57%22-15.38%
30 Sep, 229511.76%37,000,514-1.52%81.12%1.16%5624.44%2613.04%
30 Jun, 22857.59%37,571,5071.94%83.73%1.22%4540.63%23-20.69%
31 Mar, 22796.76%36,856,3341.37%82.95%1.16%32-30.43%2981.25%
31 Dec, 217412.12%36,359,3587.29%84.41%1.39%4615.00%1645.45%
30 Sep, 2166-7.04%33,889,4665.08%78.02%1.41%40-11-42.11%
30 Jun, 21711.43%32,250,7342.96%74.49%1.34%40-42.86%19-
31 Mar, 2170-31,323,171-74.62%-70---

Cullinan Oncology Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell37,723$27.82$1.05M149,859
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell5,606$30.06$168.52K129,582
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell20,277$28.54$578.71K129,582

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell37,723$27.82$1.05M149,859
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptSell50,000$4.30$215.00K138,593
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptSell5,606$4.30$24.11K132,987
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell5,606$30.06$168.52K129,582
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell20,277$28.54$578.71K129,582
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell---13,375
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell---6,250
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell26,750$17.54$469.19K-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell75,000$48.39$3.63M-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell62,500$13.60$850.00K-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell26,750$11.34$303.35K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024Meek David D.director-A-AwardBuy15,618$26.72$417.31K15,618
May 16, 2024Meek David D.-Buy----
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptBuy50,000$4.30$215.00K187,582
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell37,723$27.82$1.05M149,859
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptSell50,000$4.30$215.00K138,593
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptBuy5,606$4.30$24.11K135,188
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerM-ExemptSell5,606$4.30$24.11K132,987
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell5,606$30.06$168.52K129,582
May 08, 2024Michaelson Jenniferofficer Chief Scientific OfficerS-SaleSell20,277$28.54$578.71K129,582
Apr 30, 2024Fenton Mary Kayofficer Chief Financial OfficerA-AwardBuy200,000$27.12$5.42M200,000
Apr 30, 2024Fenton Mary Kay-Buy----
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell---13,375
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell---6,250
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell26,750$17.54$469.19K-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell75,000$48.39$3.63M-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell62,500$13.60$850.00K-
Apr 02, 2024Nguyen Nateofficer Interim PAO and PFOSell26,750$11.34$303.35K-
Feb 23, 2024Savill Corrineofficer Chief Business OfficerA-AwardBuy37,500--203,490
Feb 23, 2024Savill Corrineofficer Chief Business OfficerA-AwardBuy75,000$17.54$1.32M75,000
Feb 23, 2024AHMED NADIMdirector, officer President and CEOA-AwardBuy320,000$17.54$5.61M320,000

The last insider sell of Cullinan Oncology's stock was made by Michaelson Jennifer on May 08 2024, selling 37,723 shares at $27.82 per share (valued at $1.05M).

Cullinan Oncology Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20244580.00%
Q1 20241616100.00%
Q4 2023-11-
Q2 202372528.00%
Q1 2023178212.50%
Q4 202232150.00%
Q3 20222922.22%
Q2 20221612133.33%
Q1 20221511500.00%
Q4 202131225.00%
Q3 2021118712.64%
Q1 2021374190.24%

4 total buy trades, and 5 total sell trades (buy/sell ratio of 0.80%) were made by Cullinan Oncology's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-3-
Q1 2024-5-
Q4 2023-11-
Q2 2023-23-
Q1 2023-5-
Q4 2022-1-
Q3 2022-8-
Q2 20224944.44%
Q1 2022---
Q4 2021-6-
Q3 2021-81-
Q1 20216--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Cullinan Oncology's stocks.

Cullinan Oncology Peer Ownership


TickerCompany
MLYSMineralys Therapeutics, Inc.
CCCCC4 Therapeutics, Inc.
OLMAOlema Pharmaceuticals, Inc.
TALSTourmaline Bio, Inc.
IPSCCentury Therapeutics, Inc.
VORVor Biopharma Inc.
EWTXEdgewise Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
RVMDRevolution Medicines, Inc. Warrant
GLUEMonte Rosa Therapeutics, Inc.
SANASana Biotechnology, Inc.
LYELLyell Immunopharma, Inc.
ZNTLZentalis Pharmaceuticals, Inc.
BOLTBolt Biotherapeutics, Inc.
ACETAdicet Bio, Inc.
LIFEaTyr Pharma, Inc.
LYRALyra Therapeutics, Inc.
AUTLAutolus Therapeutics plc

CGEM Ownership FAQ


Cullinan Oncology is owned by institutional shareholders (92.01%), insiders (4.54%), and public (3.45%). The largest institutional shareholder of Cullinan Oncology is BIOIMPACT CAPITAL LLC (17.87% of total shares) and the top mutual fund owner is Tema ETF Trust (0.36% of total shares).

Cullinan Oncology's major institutional shareholders are BIOIMPACT CAPITAL LLC, BVF INC/IL, BLUE OWL CAPITAL HOLDINGS LP, FRANKLIN RESOURCES INC, and BLACKROCK INC.. The top five shareholders own together 44.15% of the company's share outstanding.

As of Mar 2024, there are 115 institutional shareholders of Cullinan Oncology.

BIOIMPACT CAPITAL LLC owns 7.65M shares of Cullinan Oncology, representing 17.87% of the company's total shares outstanding, valued at $130.33M (as of Mar 2024).

As of Mar 2024, BVF INC/IL holds 3.2M shares of Cullinan Oncology (CGEM), compromising 7.47% of the company, valued at $54.47M.

BLUE OWL CAPITAL HOLDINGS LP is the third largest holder of Cullinan Oncology. The company owns 2.92M of the company's shares outstanding (worth $49.84M).